Nisa Investment Advisors
VIR icon

Nisa Investment Advisors’s Vir Biotechnology VIR Stock Holding History

Nisa Investment Advisors’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42K Sell
4,123
-1,439
-26% -$13.7K ﹤0.01% 1919
2026
Q1 		$49.8K Buy
5,562
+3,467
+165% +$27.6K ﹤0.01% 1667
2025
Q4 		$12.6K Buy
2,095
+1,965
+1,512% +$11.7K ﹤0.01% 2128
2025
Q3 		$742 Buy
130
+40
+44% +$205 ﹤0.01% 2791
2025
Q2 		$454 Buy
90
+17
+23% +$91 ﹤0.01% 2887
2025
Q1 		$473 Sell
73
-708
-91% -$6.29K ﹤0.01% 2810
2024
Q4 		$5.73K Buy
781
+371
+90% +$2.93K ﹤0.01% 2243
2024
Q3 		$3.07K Buy
410
+234
+133% +$2.03K ﹤0.01% 2324
2024
Q2 		$1.57K Buy
176
+9
+5% +$86 ﹤0.01% 2415
2024
Q1 		$1.69K Buy
167
+110
+193% +$1.12K ﹤0.01% 2267
2023
Q4 		$573 Buy
57
+27
+90% +$247 ﹤0.01% 2380
2023
Q3 		$281 Sell
30
-1,392
-98% -$19.9K ﹤0.01% 2622
2023
Q2 		$34.9K Buy
1,422
+372
+35% +$9.34K ﹤0.01% 1874
2023
Q1 		$24K Hold
1,050
– – ﹤0.01% 1959
2022
Q4 		$27K Hold
1,050
– – ﹤0.01% 1970
2022
Q3 		$23K Buy
1,050
+50
+5% +$1.27K ﹤0.01% 2021
2022
Q2 		$25K Buy
1,000
+560
+127% +$13.1K ﹤0.01% 1985
2022
Q1 		$11K Sell
440
-990
-69% -$29.4K ﹤0.01% 2189
2021
Q4 		$49K Buy
1,430
+930
+186% +$36.4K ﹤0.01% 1742
2021
Q3 		$22K Hold
500
– – ﹤0.01% 2077
2021
Q2 		$24K Hold
500
– – ﹤0.01% 2103
2021
Q1 		$26K Sell
500
-660
-57% -$35.6K ﹤0.01% 2091
2020
Q4 		$31K Sell
1,160
-1,403
-55% -$45.6K ﹤0.01% 2065
2020
Q3 		$88K Buy
2,563
+2,103
+457% +$90.5K ﹤0.01% 1582
2020
Q2 		$19K Buy
460
+360
+360% +$12.1K ﹤0.01% 1788
2020
Q1 		$3K Buy
+100
New +$2.69K ﹤0.01% 2023

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Nisa Investment Advisors's VIR Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Vir Biotechnology (VIR) stake by 26% in Q2 2026, selling an estimated $13.7K and leaving 4,123 shares worth $42K. The position accounts for ﹤0.01% of the portfolio, ranked #1919.

Nisa Investment Advisors first reported a position in VIR in Q1 2020 and has held it in 26 quarters since. The position peaked at $88K in Q3 2020. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Nisa Investment Advisors held 4,123 shares of Vir Biotechnology worth $42K as of Q2 2026.
  • Nisa Investment Advisors sold 1,439 Vir Biotechnology shares in Q2 2026, an estimated $13.7K.
  • Vir Biotechnology made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1919 holding.
  • Nisa Investment Advisors first reported a position in Vir Biotechnology in Q1 2020 and has held it in 26 quarters since.
  • Nisa Investment Advisors's Vir Biotechnology position peaked at $88K in Q3 2020.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.